DrugDashboards

Theophylline

Theophylline · THEOPHYLLINE 300 mg/1 · Tablet, Extended Release · Oral · Leading Pharma, LLC

NDC 69315-0226-01 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

18 companies supply this market — deep enough that no single failure threatens the supply. The price has fallen 44% in a year, to $0.3422 per unit — and generics that get this cheap tend to get abandoned rather than defended. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.3422per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.1300per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$2.36per unitGolden State Medical Supply, Inc. · Dec 15, 2025690% of what pharmacies pay — higher than 95% of drugs with this benchmark
  • Medicaid generic ceiling (FUL)$0.3422per TABweighted avg manufacturer price $0.1370 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00$3.00Jun 2023Sep 2026$0.3422
40 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$10.27
#90 count
$30.80

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$119,912
2,510 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

8● Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • price down 39% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for theophylline (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA214950
TE code
AB
Approval date
Jan 30, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Theophylline (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
Ajanta Pharma USA Inc.THEOPHYLLINE ANHYDROUS 450 mg/1Jul 15, 2026Sep 2, 2026
Ajanta Pharma USA Inc.THEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.THEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.THEOPHYLLINE ANHYDROUS 450 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedTHEOPHYLLINE ANHYDROUS 450 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedTHEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCTHEOPHYLLINE ANHYDROUS 450 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCTHEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
AvKARETHEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Bionpharma Inc.,THEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.THEOPHYLLINE ANHYDROUS 450 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.THEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCTHEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USATHEOPHYLLINE ANHYDROUS 400 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USATHEOPHYLLINE ANHYDROUS 600 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USATHEOPHYLLINE ANHYDROUS 450 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USATHEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.THEOPHYLLINE ANHYDROUS 600 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.THEOPHYLLINE ANHYDROUS 400 mg/1Jul 15, 2026Sep 2, 2026
Harman Finochem LimitedTHEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Harman Finochem LimitedTHEOPHYLLINE ANHYDROUS 450 mg/1Jul 15, 2026Sep 2, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.THEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.THEOPHYLLINE ANHYDROUS 450 mg/1Jul 15, 2026Sep 2, 2026
Leading Pharma, LLCTHEOPHYLLINE 300 mg/1Jul 15, 2026Sep 2, 2026
Leading Pharma, LLCTHEOPHYLLINE 450 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.THEOPHYLLINE ANHYDROUS 450 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.THEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Strides Pharma Science LimitedTHEOPHYLLINE ANHYDROUS 450 mg/1Jul 15, 2026Sep 2, 2026
Strides Pharma Science LimitedTHEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals, Inc.THEOPHYLLINE 300 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals, Inc.THEOPHYLLINE 450 mg/1Jul 15, 2026Sep 2, 2026
Viona Pharmaceuticals IncTHEOPHYLLINE ANHYDROUS 450 mg/1Jul 15, 2026Sep 2, 2026
Viona Pharmaceuticals IncTHEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedTHEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedTHEOPHYLLINE ANHYDROUS 450 mg/1Jul 15, 2026Sep 2, 2026
Brandywine Pharmaceuticals, LLCTHEOPHYLLINE ANHYDROUS 300 mg/1Jul 15, 2026Jul 29, 2026
Brandywine Pharmaceuticals, LLCTHEOPHYLLINE ANHYDROUS 200 mg/1Jul 15, 2026Jul 29, 2026
Brandywine Pharmaceuticals, LLCTHEOPHYLLINE ANHYDROUS 100 mg/1Jul 15, 2026Jul 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Theophylline — NDC 69315-0226-01," retrieved September 3, 2026, https://drugdashboards.com/drug/69315022601.

Free to cite with attribution — see how the data is put together.